As of 2025-06-26, the EV/EBITDA ratio of Amryt Pharma Holdings Ltd (AMYT.L) is -27.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AMYT.L's latest enterprise value is 511.27 mil GBP. AMYT.L's TTM EBITDA according to its financial statements is -18.55 mil GBP. Dividing these 2 quantities gives us the above AMYT.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 13.5x | 6.9x |
| Forward P/E multiples | 5.2x - 9.1x | 6.6x |
| Fair Price | (41.30) - (58.21) | (47.97) |
| Upside | -128.9% - -140.7% | -133.5% |
| Date | EV/EBITDA |